From left to right: Ulrik Spork, Dr.Claudia Colciago
Copenhagen, Denmark, 09/03/2023
Today Cerebriu announced the appointment of Ulrik Spork and Dr.Claudia Maria Colciago to the Board. Ulrik Spork is active as Chairman, board member, and advisor in several emerging life-science and MedTech companies as well as two venture/PE funds-of-funds. For over 25 years Ulrik held senior positions in the Novo Group, where he effectively executed Novo Nordisk’s corporate development activities. He also founded and led as Senior/Managing Partner the Venture, Growth Equity, and Principal Investment activities in Novo Holdings A/S. He holds a master’s degree in engineering from DTU-Technical University of Denmark.
Dr. Claudia Maria Colciago is a Senior Investment Manager in Denmark’s Export and Investment Fund and member of several boards. She previously held positions such as Associate Director at Takeda Digital Ventures. Prior to that, at MTIP she led a $20m+ financing round in Oviva and partook in the first and following investment in other portfolio companies such as Coramaze, Blueprint Genetics, Tyto Care, Lumeon, and Cynerio. She has a Ph.D. in Applied Mathematics from the École Polytechnique fédérale de Lausanne (EPFL), and a post-doc, where she led a proof-of-concept project of a digital health start-up.
“We are absolutely thrilled to have Ulrik Spork and Claudia Colciago join our Board of Directors,” says Robert Lauritzen, CEO of Cerebriu. “Their knowledge and experience in capital formation and scaling digital health startups will provide us with invaluable insights and guidance as we continue to expand our reach and impact in the healthcare industry. Ulrik and Claudia bring a wealth of industry expertise and a strong track record of success to the table, and we are confident that they will make a significant contribution to the success of Cerebriu. We look forward to working together to achieve our mission of transforming radiology and improving patient care.”
“I am excited to be joining the strong team at Cerebriu at this important point in the company’s development”, says Ulrik Spork, professional board chairman and member. “Closing a significant funding from such a strong syndicate under the current conditions, was a testament to the tangible potential of Cerebriu’s technology. I look forward to assisting Cerebriu with making significant impact on diagnostic imaging at the patient-touchpoint, enabling radiology teams to provide better and more efficient care.”
“Cerebriu is a rapidly growing business with a revolutionary product, which enables, as the result of innovation, the possibility of radical improvement of radiology services for patients and medical staff worldwide. In Denmark’s Export and Investment Fund we work to develop and support the position of strength held in Denmark within health tech, and therefore I am delighted to join such an excellent board and a strong management team. Together we combine our deep expertise in AI and radiology software development, medical imaging technologies and hardware integration, commercialization and venture investments that will set Cerebriu on the road to success,” says Claudia Colciago, Senior Investment Manager at Denmark’s Export and Investment Fund.
À propos de Cerebriu
Cerebriu aims to improve diagnostic imaging workflow efficiency, quality of care and patient outcomes. Cerebriu’s software solution, Apollo, aims to achieve this by automating image acquisition protocols and patient triage during MRI brain acquisition. Ultimately this results in improved productivity, prioritizing the right patients at the right time with less burden on clinicians.
For more information, please visit www.cerebriu.com
Oded Yair Menuhin
Responsable Développement des Partenariats Stratégiques